Welcome to BREONICS Inc. where today’s innovations are being developed into tomorrow’s medical breakthroughs.
BREONICS mission is to provide a solution to the world wide kidney shortage; the major limiting factor in kidney transplantation today.
About BREONICS
BREONICS’ Exsanguineous Metabolic Support (EMS) technology radically broadens the criteria for organ donation to include the huge cohort of patients that die every year and are never considered for donation. EMS is the first and only technology that can overcome the technical barriers that limit access to these potential donors and will more than double the number of transplantable kidneys worldwide.
“ Finally, a technology that causes the current paradigm to shift where the supply of kidneys could meet the demand.”
– Professor Gauke Koostra, M.D., Ph.D. Maastricht University, The Netherlands
About BREONICS Science and Technology
Recent News
September 01, 2010 BREONICS announces the award of a NIH $2.9 Million RC3 BRDG-SPAN SBIR Grant to begin Clinical Development of EMS to Provide more cadaveric kidneys for transplant.
August 01, 2010 BREONICS announces $200K second year R43 SBIR Funding for:“The Potential to Immunocloak Renal Allografts”.